Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.
Carter BZ, Qiu Y, Huang X, Diao L, Zhang N, Coombes KR, Mak DH, Konopleva M, Cortes J, Kantarjian HM, Mills GB, Andreeff M, Kornblau SM.
Carter BZ, et al. Among authors: mak dh.
Blood. 2012 Jul 5;120(1):173-80. doi: 10.1182/blood-2012-02-409888. Epub 2012 May 29.
Blood. 2012.
PMID: 22645176
Free PMC article.